We are studying the safety and effectiveness of combining two medications for patients with relapsed or refractory chronic lymphocytic leukemia. This research aims to understand how well the body responds to this treatment.
Health conditions and diseases that the clinical trial is designed to study and treat.
Relapsed or Refractory Chronic Lymphocytic Leukemia (R/R CLL) is a type of cancer that affects the blood and bone marrow, where the leukemia returns after treatment or does not respond to initial therapies.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
